Burns J W & Co. Inc. NY trimmed its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 12.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,023 shares of the financial services provider’s stock after selling 1,837 shares during the period. Burns J W & Co. Inc. NY’s holdings in CME Group were worth $2,874,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Salomon & Ludwin LLC purchased a new position in CME Group in the 1st quarter valued at approximately $28,000. Y.D. More Investments Ltd purchased a new position in CME Group in the 2nd quarter valued at approximately $36,000. Rise Advisors LLC purchased a new position in CME Group in the 1st quarter valued at approximately $41,000. McClarren Financial Advisors Inc. grew its position in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Finally, Asset Dedication LLC grew its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.
CME Group Trading Up 0.1 %
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.30 earnings per share. As a group, analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.05%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 52.33%.
Analysts Set New Price Targets
A number of research analysts have recently commented on CME shares. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Bank of America boosted their price target on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, TD Cowen initiated coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $213.77.
Read Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Most Volatile Stocks, What Investors Need to Know
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 9/30 – 10/4
- Top Stocks Investing in 5G Technology
- Top Streaming Companies: Who’s Winning the Battle?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.